Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001213900-19-012436
Filing Date
2019-07-10
Accepted
2019-07-10 16:27:11
Documents
1
Effectiveness Date
2019-07-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13509
  Complete submission text file 0001213900-19-012436.txt   14711
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: D/A | Act: 33 | File No.: 021-343016 | Film No.: 19949666
SIC: 2834 Pharmaceutical Preparations